Hybrid Site of Care Director, Northeast chez Glaukos Corporation
Glaukos Corporation · Boston, États-Unis d'Amérique · Hybrid
- Senior
- Bureau à Boston
Site of Care Director
Transform the way ophthalmic care is delivered at Glaukos. As our Site of Care Director, you will lead strategic initiatives to expand access to our therapies across hospitals, IDNs, and large physician organizations—optimizing where and how patients receive care. This is your opportunity to drive enterprise adoption, improve surgical efficiency, and partner with health systems to deliver innovative therapies in the most cost-effective settings.
How You’ll Make an Impact
You will lead enterprise-level strategies to transition procedures to ambulatory surgery centers (ASCs) or physician offices, streamline surgical workflows, and integrate our technologies seamlessly into health system operations. Partnering closely with Market Access, Strategic Accounts, Field Sales, Medical Affairs, and Reimbursement, you will align care delivery with reimbursement and policy trends to accelerate adoption and impact patient access.
What Will You Do?
- Site of Care Strategy Development: Execute enterprise-level strategies to drive adoption in cost-effective settings, identify transition opportunities, and align with payer incentives and policy shifts.
- Enterprise Customer Engagement: Serve as the strategic liaison for hospitals, IDNs, and academic medical centers; cultivate relationships with perioperative leaders and procurement teams; guide integration of products into surgical service lines.
- Surgical Pathway Optimization: Improve OR throughput, inventory management, and case flow to increase procedural capacity.
- Implementation & Transition Planning: Develop customized roadmaps, training protocols, and procurement workflows for smooth enterprise adoption and site-of-care transitions.
- Reimbursement & Policy Navigation: Partner with Market Access to support payer negotiations, coding/billing education, and policy monitoring for site-neutral and outpatient reimbursement models.
- Education & Clinical Support: Provide onsite training and collaborate with KOLs to ensure best practices in surgical workflow and outcomes measurement.
- Performance Tracking & Reporting: Define KPIs tied to adoption, procedural growth, and financial impact; share insights with internal leadership and enterprise customers.
- Launch & Commercial Support: Drive readiness and overcome barriers for new product launches or therapy line extensions.
How Will You Get Here?
- 15+ years in healthcare, with experience in surgical services, medical devices, ophthalmology, or site-of-care strategy.
- Proven ability to engage hospitals, IDNs, or ASCs in a consultative, enterprise-level capacity.
- Deep understanding of healthcare delivery models, outpatient reimbursement, and payer dynamics.
- Strong project management, communication, and executive relationship-building skills.
- Comfortable navigating complex clinical and operational environments without direct authority.
- Bachelor’s degree in Life Sciences, Business, Healthcare Administration, or related field.
Join us and make a lasting impact on the future of ophthalmic care—transforming how, where, and when patients receive life-changing therapies.
Company
Generous. Innovative. Leadership-driven. Family-oriented. Socially responsible.
Founded in 1998, Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
Our mission at Glaukos is to truly transform vision by pioneering novel, dropless therapies that can meaningfully advance the standard of care and improve the lives of patients suffering from chronic, sight-threatening eye diseases.
Innovation is at the core of everything we do, and we are resolute in our commitment to challenge conventional thinking with new treatment alternatives that are supported by real science, robust clinical evidence, and an unrelenting focus on patients.
Our constant pursuit of game-changing technologies that disrupt legacy treatment paradigms is encapsulated in the Glaukos mantra “We’ll Go First,” which articulates our willingness to take chances, our determination to forge new ground, and our commitment to continuous improvement in all that we do.
Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol “GKOS”. Our global headquarters is in Aliso Viejo, California with additional locations in San Clemente, California, and Burlington, Massachusetts.
Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law.
